IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Milano.

AIR nasce in UNIMI nel 2006 con lo scopo di raccogliere, documentare e conservare le informazioni sulla produzione scientifica dell'Università degli Studi di Milano e costituisce di fatto l'Anagrafe della ricerca dell'Ateneo.

MAZZOLARI, ANGELICA

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

Nome completo

MAZZOLARI, ANGELICA

Afferenza

Dipartimento di Scienze Farmaceutiche

Pubblicazioni

Risultati 1 - 20 di 36 (tempo di esecuzione: 0.001 secondi).

	Titolo	Data di pubblicazione	Autori	Tipo	File	Abstract
1	Approaching pharmacological space: Events and components	2018	VISTOLI, GIULIO ; PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; Testa, Bernard	Book Part (author)	riservati
2	Binding space concept : a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity	24-lug-2017	VISTOLI, GIULIO ; MAZZOLARI, ANGELICA ; Testa, Bernard; PEDRETTI, ALESSANDRO	Article (author)	riservati
3	A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE)	apr-2017	DEGANI, GENNY ; ALTOMARE, ALESSANDRA ANNA ; M. Colzani; C. Martino; MAZZOLARI, ANGELICA ; G. Fritz; VISTOLI, GIULIO ; POPOLO, LAURA MARIA ; ALDINI, GIANCARLO	Article (author)	Open Access
4	Carbachol dimers as homobivalent modulators of muscarinic receptors	15-mag-2016	R. Matucci; M. Nesi; M. V. Martino; C. Bellucci; D. Manetti; E. Ciuti; MAZZOLARI, ANGELICA ; S. Dei; L. Guandalini; E. Teodori; VISTOLI, GIULIO ; M. N. Romanelli	Article (author)	-
5	Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors	15-set-2020	Matucci, Rosanna; Bellucci, Cristina; Martino, Maria Vittoria; Nesi, Marta; Manetti, Dina; Welzel, Jessica; Bartz, Ulrike; Holze, Janine; Tränkle, Christian; Mohr, Klaus; MAZZOLARI, ANGELICA ; VISTOLI, GIULIO ; Dei, Silvia; Teodori, Elisabetta; Romanelli, Maria Novella	Article (author)	Solo autorizzati
6	Computational approaches in the rational design of improved carbonyl quenchers : focus on histidine containing dipeptides	set-2016	VISTOLI, GIULIO ; COLZANI, MARA ; MAZZOLARI, ANGELICA ; D. D. Maddis; GRAZIOSO, GIOVANNI ; PEDRETTI, ALESSANDRO ; CARINI, MARINA ; ALDINI, GIANCARLO	Article (author)	riservati
7	Data from docking simulations to develop an efficient strategy able to evaluate the interactions between RAGE and MDA-induced albumin adducts	mag-2017	MAZZOLARI, ANGELICA ; COPPA, CRESCENZO ; ALTOMARE, ALESSANDRA ANNA ; DEGANI, GENNY ; VISTOLI, GIULIO	Article (author)	Open Access
8	Enhancing the reliability of GPCR models by accounting for flexibility of their pro-containing helices : The case of the human mAChR1 receptor	apr-2015	PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; C. Ricci; VISTOLI, GIULIO	Article (author)	-
9	FAME 3 : Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes	ago-2019	Sicho M.; Stork C.; MAZZOLARI, ANGELICA ; De Bruyn Kops C.; PEDRETTI, ALESSANDRO ; Testa B.; VISTOLI, GIULIO ; Svozil D.; Kirchmair J.	Article (author)	-
10	GLORYx : Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics	15-feb-2021	de Bruyn Kops C.; Sicho M.; MAZZOLARI, ANGELICA ; Kirchmair J.	Article (author)	Open Access
11	Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock : a parallelized tool based on AutoDock 4.0	2010	VISTOLI, GIULIO ; PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; B. Testa	Article (author)	-
12	Impact of the Journal of Chemical Information and Modeling Special Issue on Women in Computational Chemistry	27-lug-2020	MAZZOLARI, ANGELICA ; Nunes-Alves A.; Wahab H. A.; Amaro R. E.; Cournia Z.; Merz K. M.	Article (author)	riservati
13	Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs	2015	D. Tronino; R. Russo; C. Ostacolo; MAZZOLARI, ANGELICA ; C. De Caro; C. Avagliano; S. Laneri; G. La Rana; A. Sacchi; F. Della Valle; VISTOLI, GIULIO ; A. Calignano	Article (author)	-
14	IN SILICO APPROACHES IN DRUG DESIGN AND DEVELOPMENT: APPLICATIONS TO RATIONAL LIGAND DESIGN AND METABOLISM PREDICTION	21-dic-2015	MAZZOLARI, ANGELICA	Doctoral Thesis	Open Access
15	In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations	2010	VISTOLI, GIULIO ; PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; B. Testa	Article (author)	-
16	In silico prediction of metabolism by human carboxylesterase-1 (hCES1) combining docking analyses and MD simulations	8-feb-2009	VISTOLI, GIULIO ; PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; B. Testa	Conference Object	Open Access	-
17	Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study	2009	VISTOLI, GIULIO ; PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; BOLCHI, CRISTIANO ; B. Testa	Article (author)	-
18	Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors : an integrated approach to behaviorally active nicotinic ligands	27-set-2012	H. Zhang; J. B. Eaton; L. Yu; M. Nys; MAZZOLARI, ANGELICA ; R. van Elk; A. B. Smit; V. Alexandrov; T. Hanania; E. Sabath; A. Fedolak; D. Brunner; R. J. Lukas; VISTOLI, GIULIO ; C. Ulens; A. P. Kozikowski	Article (author)	-
19	MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data	8-feb-2018	PEDRETTI, ALESSANDRO ; MAZZOLARI, ANGELICA ; VISTOLI, GIULIO ; B. Testa	Article (author)	riservati
20	Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites	1-ago-2014	F. Del Bello; A. Bonifazi; W. Quaglia; MAZZOLARI, ANGELICA ; E. Barocelli; S. Bertoni; R. Matucci; M. Nesi; A. Piergentili; VISTOLI, GIULIO	Article (author)	riservati